All In Biotech

Drug Trial Radar · NCT05147220

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment With Open-label Remibrutinib

Last checked: Nov 19, 2026Latest source record: Aug 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 1,000 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

1,000

Actual

Start

Dec 16, 2021

Primary completion

Jul 21, 2026

Study completion Oct 30, 2030

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Dec 7, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)

Conditions

  • Relapsing Multiple Sclerosis

Interventions

  • RemibrutinibDrug

    tablet taken orally

  • TeriflunomideDrug

    capsule taken orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Annualized relapse rate (ARR) of confirmed relapses [Core Part]Time frame: From Baseline, up to 30 months

Locations

200 sites in 34 countries. Site status is shown where the registry gives one.

  • AZ Integrated Neuro and Spine

    Phoenix, Arizona

  • Center for Neurosciences

    Tucson, Arizona

  • The Belinga Clinic

    Fort Smith, Arkansas

  • The Research and Education Inst of Alta Bates Summit Med Grp

    Berkeley, California

  • The Neuron Clinic

    Chula Vista, California

  • Glendale Adventist Medical Center

    Glendale, California

  • Hoag Health System

    Newport Beach, California

  • SC3 Research Pasadena

    Pasadena, California

  • Neuro Center

    Pomona, California

  • Alpine Clinical Research Center

    Boulder, Colorado

  • Christiana Care Health Services

    Newark, Delaware

  • Washington Hospital Center

    Washington D.C., District of Columbia

  • Neurology of Central FL Res Ctr

    Altamonte Springs, Florida

  • Arrow Clinical Trials

    Daytona Beach, Florida

  • Homestead Assoc In Research Inc

    Homestead, Florida

  • Reliant Medical Research

    Miami, Florida

  • Neurological Services of Orlando PA

    Orlando, Florida

  • Orlando Health Clinical Trials

    Orlando, Florida

  • Comprehensive Neurology Clinic

    Orlando, Florida

  • Neurology Associates of Ormond Beach

    Ormond Beach, Florida

  • Neurostudies Inc

    Port Charlotte, Florida

  • Accel Research Sites St Pete-Largo

    Seminole, Florida

  • University Of South Florida

    Tampa, Florida

  • Conquest Research

    Winter Park, Florida

  • Rush University Medical Center

    Chicago, Illinois

  • IU Health Inc

    Fort Wayne, Indiana

  • College Park Family Care Center

    Overland Park, Kansas

  • Norton Neurology MS Services

    Louisville, Kentucky

  • American Oncology Partners PA Center for Cancer and Blood Disorders

    Bethesda, Maryland

  • Neurology Center of New England PC

    Foxborough, Massachusetts

  • Wayne State University Multiple Sclerosis Clinic

    Detroit, Michigan

  • The MS Center for Innovation in Care

    St Louis, Missouri

  • SCL Health

    Billings, Montana

  • Jersey Shore University Medical Ctr

    Neptune City, New Jersey

  • Neurological Associates of Long Island PC

    Lake Success, New York

  • NYU Langone Med Center CV Research

    New York, New York

  • The Neurological Institute PA

    Charlotte, North Carolina

  • Velocity Clinical Research

    Raleigh, North Carolina

  • Columbus Neuroscience

    Westerville, Ohio

  • Multiple Sclerosis Center of Excellence of OMRF

    Oklahoma City, Oklahoma

Showing 40 of 200 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.